Qingdao Baheal Medical INC.

301015

CNE100004LR8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
31.52 ^CNY	+3.14%		-4.66%	-12.10%

Apr. 22	Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Qingdao Baheal Medical Inc. Approves Cash Dividend for the Year of 2022, Payable on 25 May 2023

May 16, 2023 at 03:33 pm EDT

Qingdao Baheal Medical INC. held its Annual General Meeting of 2022 on 15 May 2023, approved Cash dividend/10 shares (tax included): CNY 7.62000000 per ten shares for 2022. Record date is 24 May 2023; Ex-date is 25 May 2023; Payment date is 25 May 2023.

Latest news about Qingdao Baheal Medical INC.

Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Certain A Shares of Qingdao Baheal Medical INC. are subject to a Lock-Up Agreement Ending on 1-JUL-2023.	23-06-30	CI
Qingdao Baheal Medical Inc. Approves Cash Dividend for the Year of 2022, Payable on 25 May 2023	23-05-16	CI
Qingdao Baheal Medical INC. Announces Final Cash Dividend Proposal for 2022	23-04-25	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Qingdao Baheal Medical INC.(XSEC:301015) added to S&P Global BMI Index	22-09-19	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-16	CI
Qingdao Baheal Medical Inc. Announces Management Appointments	22-08-05	CI
Sinohealth Raises $43 Million in Hong Kong IPO	22-07-10	MT
Certain A Shares of Qingdao Baheal Medical INC. are subject to a Lock-Up Agreement Ending on 1-JUL-2022.	22-06-30	CI
Qingdao Baheal Medical to List 12.5% Stake Post IPO Lock-Up	22-06-29	MT
Qingdao Baheal Medical INC. Announces Final Dividend on A Shares for the Year 2021, Payable on May 25, 2022	22-05-19	CI
Qingdao Baheal Medical Inc. Approves Dividend for 2021	22-05-17	CI
Qingdao Baheal Medical INC. Announces Final Cash Dividend Proposal for 2021	22-04-26	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Qingdao Baheal Medical to List 2.9 Million Shares Post IPO Lockup Period	21-12-29	MT
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Qingdao Baheal Medical INC. has completed an IPO in the amount of CNY 401.864 million.	21-06-22	CI
Qingdao Baheal Medical INC. has filed an IPO.	20-11-23	CI

Chart Qingdao Baheal Medical INC.

Duration

Period

More charts

Company Profile

Qingdao Baheal Medical Inc is a China-based company mainly providing comprehensive marketing services for pharmaceutical product manufacturers. The Company provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The Company's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The Company mainly conducts its business within domestic market.

Sector

Pharmaceuticals

Calendar

2024-05-13 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Qingdao Baheal Medical INC.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

31.52 CNY

Average target price

51 CNY

Spread / Average Target

+61.80%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
QINGDAO BAHEAL MEDICAL INC.	-12.10%	2.29B
MCKESSON CORPORATION	+17.35%	71.39B
CARDINAL HEALTH, INC.	+2.39%	25.1B
SINOPHARM GROUP CO. LTD.	-2.59%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
GALENICA AG	-2.61%	3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+22.08%	3.64B

Pharmaceuticals Wholesale